Policy & Regulation

FDA warns OTC drug manufacturer for drug manufacturing data integrity violations

FDA warns OTC drug manufacturer for drug manufacturing data integrity violations

21 Aug 2019

Company provided FDA investigators with multiple documents that were falsified.

Read more 
FDA approves Aptar's needle-free rescue treatment for severe hypoglycemia

FDA approves Aptar's needle-free rescue treatment for severe hypoglycemia

25 Jul 2019

Aptar’s nasal Unidose device - the result of a 10-year customer collaboration - marks the first FDA approval of a prescription drug using the company’s patented Unidose Powder System.

Read more 
Legacy ramps up preparations for new Russian track and trace sterilisation regulations

Legacy ramps up preparations for new Russian track and trace sterilisation regulations

18 Jul 2019

Company to install new inspection cameras with higher resolution to ensure readability of more complex codes demanded by the Russian mandated crypto coding.

Read more 
Particle Sciences expands controlled substance capabilities

Particle Sciences expands controlled substance capabilities

27 May 2019

Now authorized to test, develop and manufacture cannabis-derived pharmaceutical materials.

Read more